Gale Smith
Chief Tech/Sci/R&D Officer presso NOVAVAX, INC.
Profilo
Il dottor Gale E. Smith è Chief Scientist e Senior Vice President-Discovery di Novavax, Inc. Si è laureato all'Università del Nord Dakota e ha conseguito il dottorato alla Texas A&M University.
Posizioni attive di Gale Smith
Società | Posizione | Inizio |
---|---|---|
NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Gale Smith
Società | Posizione | Fine |
---|---|---|
Protein Sciences Corp.
Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT. | Chief Tech/Sci/R&D Officer | - |
Formazione di Gale Smith
Texas A&M University | Doctorate Degree |
University of North Dakota | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NOVAVAX, INC. | Health Technology |
Aziende private | 1 |
---|---|
Protein Sciences Corp.
Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT. | Health Technology |